Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study finds limitations in publicly reported quality-of-care indicators for heart-failure patients

05.01.2007
Beta-blocker measure superior to all existing indicators

Academic researchers reported that all five standard hospital-based performance measures used to gauge quality of care for hospitalized heart failure patients may not be the best benchmarks since none were significant predictors of patient mortality during the critical first 60 to 90 days immediately following hospital discharge.

Published in the Jan. 3 issue of the Journal of the American Medical Association, the study found that none of the current measures used by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) which accredits hospitals and by the Federal Government through the Center for Medicare and Medicaid Services (CMS) to assess hospital performance were associated with a lower risk of mortality during the days immediately following hospital discharge when adverse events are most likely to occur.

Only one of the standard measures modestly influenced mortality and rehospitalization rates. Researchers also reported that use of beta blocker medications in eligible heart failure patients at time of hospital discharge, currently not a JCAHO/CMS performance measure, was associated with the most significant improvements in heart failure patient outcomes – predictive of a 52 percent reduction in mortality during the first 60 to 90 day period after hospital discharge.

Professional societies, health care accrediting organizations, the government, and major insurers use performance measures to rank and accredit hospitals, rate quality of care, and develop hospital as well as physician pay-for- performance initiatives. According to researchers, performance measures should reflect the strongest clinical evidence in practice and failure to perform these key treatments should reduce the likelihood of optimal patient outcomes.

"The study's findings are quite surprising since it has been commonly held that existing performance measures could be used to distinguish hospitals that provide higher quality heart failure care and that these indicators were strongly linked to clinical outcomes." said Dr. Gregg C. Fonarow, The Eliot Corday Chair in Cardiovascular Medicine and Science, principal investigator and director, Ahmanson-UCLA Cardiomyopathy Center.

Fonarow added that the findings do not lessen the importance of providing recommended elements of heart failure care covered by the existing performance measures nor does it preclude these measures from influencing patient quality-of-life or long-term survival.

However, Fonarow noted that the study does demonstrate that the factors influencing mortality and rehospitalization after discharge for heart failure may be driven by a different set of care processes and better methods for identifying and validating new performance measures are needed.

Researchers utilized data on 5,791 patients seen at 91 hospitals, taken from a large heart failure patient registry and performance improvement program called the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

Researchers statistically analyzed the relationship between the five standard performance measures and clinical outcomes within the 60 to 90 days after patient discharge. Four of these heart failure measures are currently used by JCAHO/CMS and are publicly reported on the Hospital Compare website: http://www.hospitalcompare.hhs.gov.

The five measures, developed by the American College of Cardiology and the American Heart Association, included: 1) Giving complete medical instructions to patients upon hospital discharge; 2) Evaluation of the heart's left ventricle systolic function; 3) Prescribing patients an angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blockers (ARB) drugs; 4) Smoking cessation counseling and 5) Prescribing anticoagulation for atrial fibrillation.

Researchers also evaluated prescribing of a beta-blocker at hospital discharge, another key medication for heart failure that currently is not assessed with a performance measure.

The study determined that none of the five standard measures were significantly associated with reduced early mortality risk and only ACE inhibitor or ARB use modestly affected mortality or rehospitalization outcomes. Prescribing a beta-blocker in eligible patients, however, was strongly associated with lower mortality risk and lower death/rehospitalization risk.

"This study has identified and validated a new performance measure that could be used to augment existing measures and more effectively quantify the quality of care provided to heart failure patients in the hospital setting" said Fonarow. "If this beta-blocker measure was adopted by JCAHO/CMS and the levels of performance achieved by OPTIMIZE-HF hospitals in providing beta blockers were achieved by hospitals nationwide, we estimate that an additional 19,000 lives a year could be saved."

The investigators noted that while performance measures for heart attack have a strong association with mortality outcomes, the connection for heart failure measures have not been as well studied.

"While the current performance measures for heart failure have some rationale for their continued use, in determining which measures should be publicly reported and used for pay-for- performance programs, there should be better selection of measures that significantly influence patient outcomes early after hospital discharge." said Fonarow, Professor of Medicine, UCLA Division of Cardiology.

Fonarow added that it may be helpful to require hospitals to report actual patient outcomes such as mortality or mortality/rehospitalization rates in the first 30-90 days post-discharge to help track and identify which hospitals are providing better care. Currently hospitals only report in-hospital process of care data.

Only the American Heart Association's Get With The Guidelines – Heart Failure program, one of the national quality improvement programs for heart failure, routinely collects and reports on a beta-blocker performance measure for patients hospitalized with heart failure.

Heart failure is the leading cause of hospitalization in those over age 65 -- almost 3.6 million hospitalizations are attributed to heart failure as the primary or a secondary discharge diagnosis each year. The estimated direct and indirect costs of heart failure in 2006 are expected to be $29.6 billion. Heart failure occurs when the heart cannot pump enough blood to the body's other organs. The heart keeps working but not as efficiently as it should. This condition is caused by narrowed arteries, heart attack, high blood pressure, heart defects, infection or disease of the heart muscle or valves.

Rachel Champeau | EurekAlert!
Further information:
http://www.mednet.ucla.edu

More articles from Studies and Analyses:

nachricht A sudden drop in outdoor temperature increases the risk of respiratory infections
11.01.2017 | University of Gothenburg

nachricht Urbanization to convert 300,000 km2 of prime croplands
27.12.2016 | Mercator Research Institute on Global Commons and Climate Change (MCC) gGmbH

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>